ProductsBack/FOXM1 antibody [C3], C-term

FOXM1 antibody [C3], C-term

Name: FOXM1 antibody [C3], C-term
SKU: GTX100276_G10
Availability: BackOrder

GTX100276

ApplicationsWestern Blot, ChIP Chromatin ImmunoPrecipitation

Product group Antibodies

ReactivityHuman

TargetFOXM1

Overview

Supplier
GeneTex
Product Name
FOXM1 antibody [C3], C-term
Delivery Days Customer
9
Application Supplier Note
WB: 1:1000-1:10000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Applications
Western Blot, ChIP Chromatin ImmunoPrecipitation
Certification
Research Use Only
Clonality
Polyclonal
Concentration
1.52 mg/ml
Conjugate
Unconjugated
Gene ID2305
Target name
FOXM1
Target description
forkhead box M1
Target synonyms
FKHL16, FOXM1A, FOXM1B, FOXM1C, HFH-11, HFH11, HNF-3, INS-1, MPHOSPH2, MPP-2, MPP2, PIG29, TRIDENT, forkhead box protein M1, Forkhead, drosophila, homolog-like 16, HNF-3/fork-head homolog 11, M-phase phosphoprotein 2, MPM-2 reactive phosphoprotein 2, forkhead box M1-D, forkhead-related protein FKHL16, hepatocyte nuclear factor 3 forkhead homolog 11, transcription factor Trident, winged-helix factor from INS-1 cells
Host
Rabbit
Isotype
IgG
Protein IDQ08050
Protein Name
Forkhead box protein M1
Reactivity
Human
Storage Instruction
-20°C or -80°C,2°C to 8°C
UNSPSC
12352203

References

Wuputra K, Hsiao PJ, Chang WT, et al. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. Int J Mol Sci. 2022,23(14). doi: 10.3390/ijms23147782
Read this paper
Huang TL, Chang CR, Chien CY, et al. DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis. Mol Oncol. 2022,16(13):2585-2606. doi: 10.1002/1878-0261.13212
Read this paper
Ros S, Wright AJ, D'Santos P, et al. Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER(+) Breast Cancer. Cancer Cell. 2020,38(4):516-533.e9. doi: 10.1016/j.ccell.2020.08.016
Read this paper
Yang JS, Lee CY, Cho HC, et al. ITR‑284 modulates cell differentiation in human chronic myelogenous leukemia K562 cells. Oncol Rep. 2018,39(1):383-391. doi: 10.3892/or.2017.6090
Read this paper
Otto-Duessel M, Tew BY, Vonderfecht S, et al. Identification of neuron selective androgen receptor inhibitors. World J Biol Chem. 2017,8(2):138-150. doi: 10.4331/wjbc.v8.i2.138
Read this paper
Ju SY, Huang CY, Huang WC, et al. Identification of thiostrepton as a novel therapeutic agent that targets human colon cancer stem cells. Cell Death Dis. 2015,6(7):e1801. doi: 10.1038/cddis.2015.155
Read this paper
Sanders DA, Gormally MV, Marsico G, et al. FOXM1 binds directly to non-consensus sequences in the human genome. Genome Biol. 2015,16(1):130. doi: 10.1186/s13059-015-0696-z
Read this paper
Chen PM, Cheng YW, Wang YC, et al. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis. Neoplasia. 2014,16(11):961-71. doi: 10.1016/j.neo.2014.09.010
Read this paper
Bergamaschi A, Madak-Erdogan Z, Kim YJ, et al. The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells. Breast Cancer Res. 2014,16(5):436. doi: 10.1186/s13058-014-0436-4
Read this paper
Sanders DA, Ross-Innes CS, Beraldi D, et al. Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells. Genome Biol. 2013,14(1):R6. doi: 10.1186/gb-2013-14-1-r6
Read this paper

Datasheet

Download Datasheet

FAQ

Go to our frequently asked questions

FOXM1 antibody [C3], C-term

Large volume orders?

Overview

References

Datasheet

FAQ

Related products